"Antimicrobial resistance costs money, livelihood, and lives, and threatens to undermine the effectiveness of health delivery programs. It has been described as a threat to global stability and national security. Antimicrobial use is the key driver of resistance. This selective pressure comes from a combination of overuse... and also from misuse."
-WHO Global Strategy for Containment of Antimicrobial Resistance, 2000.
Through a joint effort of Pharmaceutical & Nutrition Care, Infection Control and Epidemiology, and the Infectious Diseases Division of Internal Medicine, the Antimicrobial Stewardship Program (ASP) at Nebraska Medicine has been active since August 2004. The mission of the ASP is to optimize the utilization of antimicrobial agents in order to realize improved patient outcomes, a positive effect on antimicrobial resistance, and an economic benefit.
Antimicrobial stewardship is defined as a rational, systematic approach to the use of antimicrobial agents in order to achieve optimal outcomes. This means using the right agent, at the correct dose, for the appropriate duration in order to cure or prevent infection, while minimizing toxicity and emergence of resistance.
Nebraska Medicine: Five part series on Antimicrobial Stewardship in Long-term Care Facilities
- Antimicrobial Stewardship and Long-term Care Facilities: Introduction - Video 1 (11 min.)
- What is Antimicrobial Stewardship - Video 2 (10 min.)
- Antimicrobial Stewardship in Long-term Care Facilities - Video 3 (10 min.)
- Stewardship Interventions in Long-term Care Facilities - Video 4 (16 min.)
- Interpreting Clinical Microbiology Reports - Video 5 (15 min.)